Lataa...
SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
BACKGROUND: Randomized clinical trials (RCTs) of interventions for the hepatitis C virus have historically used sustained virological response (SVR) at 24 weeks after treatment (SVR24) as the key effect measure. However, recent RCTs investigating the efficacy of new direct acting agents (DAAs) have...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3897323/ https://ncbi.nlm.nih.gov/pubmed/24474846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S53302 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|